Generics - USA

Filter

Current filters:

USA

Popular Filters

1 to 25 of 166 results

Over 80% of Americans would buy generic Rx drug more often than branded product

Over 80% of Americans would buy generic Rx drug more often than branded product

17-03-2015

Americans favor generic prescription drugs over brand name products by a considerable margin, according…

GenericsMarkets & MarketingPharmaceutical sciencesPharmaceuticals policyUSA

Actavis confirms Appeals Court grants injunction over generic Pulmicort Respules

Actavis confirms Appeals Court grants injunction over generic Pulmicort Respules

13-03-2015

Ireland-headquartered generics major Actavis has confirmed that the US Court of Appeals for the Federal…

ActavisAstraZenecaGenericsLegalPulmicort RespulesRespiratory and PulmonaryUSA

US FTC calls for divestitures for Impax buy of CorePharma to proceed

US FTC calls for divestitures for Impax buy of CorePharma to proceed

09-03-2015

US Federal Trade Commission imposes divestiture conditions on proposed acquisition by generic drugmaker…

CorePharmaGenericsImpax LaboratoriesMergers & AcquisitionsPerrigoPilocarpineRegulationUrsodiolUSA

US court rules Actavis’ Atelvia patents invalid

US court rules Actavis’ Atelvia patents invalid

05-03-2015

The US District Court for the District of New Jersey has found that Ireland-headquartered Actavis’…

ActavisAnti-Arthritics/RheumaticsAtelviaGenericsLegalPatentsRisedronate SodiumTeva Pharmaceutcal IndustriesUSAWomen's Health

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

03-03-2015

US generic drugmaker Mylan has reported strong growth throughout the company for the fourth quarter and…

FinancialGenericsMylanPharmaceutical sciencesUSA

TWi Pharmaceuticals to use its own subsidiary in USA instead of Teva

24-02-2015

Generic drugmakers Taiwan-based TWi Pharmaceuticals and Israeli company Teva Pharmaceutical Industries…

GenericsLicensingLidodermMegace ESOncologyTeva Pharmaceutcal IndustriesTWi PharmaceuticalsUSA

Actavis receives final FDA approval for generic version of Subutex

Actavis receives final FDA approval for generic version of Subutex

22-02-2015

Ireland-headquartered generics major Actavis has received final approval from the US Food and Drug Administration…

Abbreviated New Drug ApplicationGenericsIndiviorNeurologicalRC PharmaceuticalsReckitt BenckiserRegulationSubutexUSA

Actavis’ fourth-qtr 2014 beats expectations

Actavis’ fourth-qtr 2014 beats expectations

18-02-2015

Ireland-headquartered generics major Actavis posted better-than-expected fourth-quarter and full-year…

AccountancyActavisAllerganFinancialForest LaboratoriesGenericsPharmaceuticalThomson ReutersUSA

Lupin links with Celon Pharma for generic Advair Diskus

Lupin links with Celon Pharma for generic Advair Diskus

18-02-2015

Indian drug major Lupin has entered into a definitive agreement with Polish drugmaker Celon Pharma to…

Advair DiskusCanadaCelon PharmaGenericsGlaxoSmithKlineLicensingLupinMarkets & MarketingMexicoRespiratory and PulmonaryUSA

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Actavis launches generic Pulmicort Respules in USA

14-02-2015

Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Breckenridge Pharma files ANDA for generic of Sanofi’s Jevtana

12-02-2015

Privately-held US generic drugmaker Breckenridge Pharmaceutical has filed an Abbreviated New Drug Application…

Breckenridge PharmaceuticalsGenericsJevtanaOncologyPatentsRegulationSanofiUSA

Mylan confirms it is being sued by Bayer over Nexavar patent challenge

Mylan confirms it is being sued by Bayer over Nexavar patent challenge

10-02-2015

US generics drugmaker Mylan has confirmed that it has been sued by German pharma major Bayer and partner…

BayerGenericsLegalMylanNexavarOncologyOnyx PharmaceuticalsPatentsPatents & Trade marksRegulationUSA

Actavis to divest Doryx brand to Mayne Pharma for $50 million

Actavis to divest Doryx brand to Mayne Pharma for $50 million

10-02-2015

Ireland-headquartered generics major Actavis has entered an agreement with Mayne Pharma to divest the…

ActavisDermatologicalsDoryxFinancialGenericsLicensingMayne PharmaUSA

US FDA issues another warning letter over failures at Apotex’ Indian plant

US FDA issues another warning letter over failures at Apotex’ Indian plant

09-02-2015

The US Food and Drug Administration has issued yet another warning letter to Canada-headquartered generics…

ApotexApotex Research Private LimitedGenericsIndiaProductionRegulationUSA

Orexo files US patent infringement law suit against Actavis for Abstral

Orexo files US patent infringement law suit against Actavis for Abstral

06-02-2015

Sweden-based pharma company Orexo has filed a patent infringement law suit in the US District Court for…

AbstralActavisAnalgesiaGenericsLegalOrexoUSA

US FDA approves first generic of AstraZeneca’s Nexium

US FDA approves first generic of AstraZeneca’s Nexium

27-01-2015

The US Food and Drug Administration yesterday approved a generic version of Nexium (esomeprazole), Anglo-Swedish…

AstraZenecaGastro-intestinalsGenericsNexiumRegulationTeva Pharmaceutcal IndustriesUSA

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

26-01-2015

US biotech major Gilead Sciences has expanded its hepatitis C generic licensing agreements to include…

Anti-viralsBiotechnologyGenericsGilead SciencesIndiaLicensingSovaldiUSA

Supernus sues TWi for infringement of Oxtellar XR patents

22-01-2015

US drugmaker Supernus Pharmaceuticals says that it has sued generic drug makers Taiwan-based TWi Pharmaceuticals…

GenericsLegalNeurologicalOxtellar XRPatentsSupernus PharmaceuticalsTWi PharmaceuticalsUSA

Supernus sues Par for Trokendi XR patents infringement

19-01-2015

US drugmaker Supernus Pharmaceuticals says it has sued privately-held generics firm Par Pharmaceutical…

GenericsLegalNeurologicalPar PharmaceuticalsPatentsSupernus PharmaceuticalsTrokendi XRUSA

1 to 25 of 166 results

Back to top